Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.3390/molecules27217264

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorFuster, M. G.-
dc.contributor.authorMoulefera, I.-
dc.contributor.authorMontalbán, M. G.-
dc.contributor.authorPérez, J.-
dc.contributor.authorVíllora, G.-
dc.contributor.authorGarcía, G.-
dc.contributor.otherFacultad de Químicaes
dc.date.accessioned2025-07-17T08:38:08Z-
dc.date.available2025-07-17T08:38:08Z-
dc.date.issued2022-10-26-
dc.identifier.citationMolecules 2022, 27(21), 7264es
dc.identifier.issn1420-3049-
dc.identifier.urihttp://hdl.handle.net/10201/157481-
dc.description© 2022 by the authors____ This document is the published version of a published work that appeared in final form in Molecules____ This document is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by/4.0 ____ To access the final edited and published work see: https://doi.org/10.3390/molecules27217264-
dc.description.abstractWhen the [Ru(p-cymene)( -Cl)Cl]2 complex is made to react, in dichloromethane, with the following ligands: 2-aminobenzonitrile (2abn), 4-aminobenzonitrile (4abn), 2-aminopyridine (2ampy) and 4-aminopyridine (4ampy), after addition of hexane, the following compounds are obtained: [Ru(p-cymene)Cl2(2abn)] (I), [Ru(p-cymene)Cl2(4abn)] (II), [Ru(p-cymene)Cl2(2ampy] (III) and [Ru(pcymene) Cl2( -(4ampy)] (IV). All the compounds are characterized by elemental analysis of carbon, hydrogen and nitrogen, proton nuclear magnetic resonance, COSY 1H-1H, high-resolution mass spectrometry (ESI), thermogravimetry and single-crystal X-ray diffraction (the crystal structure of III is reported and compared with the closely related literature of II). The cytotoxicity effects of complexes were described for cervical cancer HeLa cells via 3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (MTT) assay. The results demonstrate a low in vitro anticancer potential of the complexes.-
dc.formatapplication/pdfes
dc.format.extent11es
dc.languageenges
dc.publisherMDPIes
dc.relationÁmbito del proyecto: nacional Agencia financiadora: Agencia estatal de investigación y Ministerio de Ciencia, Innovación y Universidades Convocatoria: 2020 Nombre del proyecto: BIOMATERIALES EN NANOINGENIERÍA: PRODUCCIÓN Y APLICACIONES EN TERAPIAS ANTICANCERÍGENA, ANTIBACTERIANA Y ANTIVIRAL Código o número del acuerdo de subvención: PID2020-113081RB-I00es
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectRutheniumes
dc.subjectComplexeses
dc.subjectCytotoxicityes
dc.subjectAnticancer activityes
dc.subjectHeLaes
dc.subjectMTT assayes
dc.titleSynthesis and Characterization of New Ruthenium (II) Complexes of Stoichiometry [Ru(p-Cymene)Cl2L] and Their Cytotoxicity against HeLa-Type Cancer Cellses
dc.typeinfo:eu-repo/semantics/articlees
dc.relation.publisherversionhttps://www.mdpi.com/1420-3049/27/21/7264-
dc.identifier.doihttps://doi.org/10.3390/molecules27217264-
dc.contributor.departmentIngeniería Químicaes
Aparece en las colecciones:Artículos

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
molecules-27-07264-2.pdf2,72 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons